XCUR Stock: Exicure, Inc. Stock Price, Analysis & Insights

Get live XCUR stock price $2.81, comprehensive Exicure, Inc. stock analysis, charts, news, and expert forecast. Real-time XCUR stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

2.81

1.39%Today

XCUR • Exicure, Inc. • NASDAQ Capital Market • Healthcare

Market Cap

17.91M

Volume

1.58K

52W High

9.78

52W Low

2.62

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluat...

Contact Information

Website: https://www.exicuretx.com
Address: 2430 North Halsted Street
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 3.54)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Exicure, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Exicure, Inc.
⚠Investors should consider how Exicure, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

17.91M

P/E Ratio (TTM)

-1.79

Beta

3.54

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare XCUR with peer companies:

CollPlant Biotechnologies Ltd. (CLGN)

Price: $0.37
Market cap: 4.52M

Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Price: $4.24
Market cap: 12.16M

iBio, Inc. (IBIO)

Price: $1.70
Market cap: 26.84M

Klotho Neurosciences, Inc. (KLTO)

Price: $0.38
Market cap: 20.08M

MetaVia Inc. (MTVA)

Price: $1.82
Market cap: 4.01M

NeuroSense Therapeutics Ltd. (NRSN)

Price: $0.79
Market cap: 19.46M

NeurAxis, Inc. (NRXS)

Price: $6.72
Market cap: 83.22M

Rallybio Corporation (RLYB)

Price: $16.21
Market cap: 85.88M

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Price: $1.26
Market cap: 8.43M

TAO Synergies Inc. (TAOX)

Price: $3.88
Market cap: 12.75M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.